Skip to main content
HOUSE 2482116th CongressReferred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Mainstreaming Addiction Treatment Act of 2019

Last Action
5/31/2019

Actions

  • 2019-05-31Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
  • 2019-05-03Referred to the Subcommittee on Health.
  • 2019-05-02Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2019-05-02Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2019-05-02Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2019-05-02Introduced in House
  • 2019-05-02Introduced in House

CRS Summary

As of 2019-05-02 (00)

Mainstreaming Addiction Treatment Act of 2019

This bill removes the requirement that a health care practitioner apply for a separate waiver through the Drug Enforcement Administration to dispense certain narcotic drugs (e.g., buprenorphine) for maintenance or detoxification treatment (i.e., substance use disorder treatment).

Further, the bill directs the Substance Abuse and Mental Health Services Administration to conduct a national campaign to educate health care practitioners and encourage them to integrate substance use disorder treatment into their practices.

Cosponsors (20)

  • Ben Luján (D-NM)
  • Antonio Delgado (D-NY)
  • Ted Budd (R-NC)
  • Elise Stefanik (R-NY)
  • Michael Turner (R-OH)
  • Pramila Jayapal (D-WA)
  • Yvette Clarke (D-NY)
  • LLOYD DOGGETT (D-TX)
  • GREGORY MEEKS (D-NY)
  • Jefferson Van Drew (D-NJ)
  • Doris Matsui (D-CA)
  • Harley Rouda (D-CA)
  • Mark Meadows (R-NC)
  • Anthony Brindisi (D-NY)
  • Max Rose (D-NY)
  • Joseph Kennedy (D-MA)
  • Jamie Raskin (D-MD)
  • Albio Sires (D-NJ)
  • Trey Hollingsworth (R-IN)
  • Ro Khanna (D-CA)

Subjects

  • Administrative law and regulatory procedures
  • Drug therapy
  • Drug trafficking and controlled substances
  • Drug, alcohol, tobacco use
  • Government information and archives
  • Health care coverage and access
  • Prescription drugs
Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.